NAN:ASX
Nanosonics Ltd.
A$2.84
arrow_upward
+1.43%(+0.040) 1D
Oct 9, 4:10:30 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NAN...
Open
A$2.80
High
A$2.87
Low
A$2.76
Mkt. cap
849.64M
Avg. vol.
1.17M
Volume
905.74K
P/E ratio
49.19
52-wk high
A$4.76
52-wk low
A$2.64
EPS
A$0.06
Shares outstanding
299.17M
No. of employees
508
Open
A$2.80
High
A$2.87
Low
A$2.76
Mkt. cap
849.64M
Avg. vol.
1.17M
Volume
905.74K
P/E ratio
49.19
52-wk high
A$4.76
52-wk low
A$2.64
EPS
A$0.06
Shares outstanding
299.17M
No. of employees
508
News stories
From web sources and news partners
MarketWatch
·
1 hour ago
S&P 500 at 10,000 or bust: New ETF offers investors all-or-nothing bet on the index
ChartMill
·
23 hours ago
Get insights into the top movers in the S&P500 index of Friday's pre-market session.
Proactive financial news
·
23 hours ago
Frank Talk: Gold miners beat every S&P 500 sector in Q3 despite September selloff
marketscreener.com
·
16 hours ago
S&P maintains UK's ratings at 'AA/A-1+'
Profile
Nanosonics is an ASX-listed company in the healthcare industry which manufactures and distributes ultrasound probe disinfectors and other related technologies. It has offices in Australia, the U.S. and Canada, the United Kingdom and Europe, employing more than 300 people.
The company's Trophon is the product used to reduce the spread of Healthcare Acquired Infections. Its Trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection. Wikipedia
About Nanosonics Ltd.
CEOMichael Kavanagh
Employees508
Founded2001
HeadquartersSydney, New South Wales, Australia
SectorMedical device
Websitenanosonics.com.au